ZA813141B - New 1,4-dihydropyridine compounds having different substittuents in the 2-position and 6-position, their porduction, and their medicinal use - Google Patents

New 1,4-dihydropyridine compounds having different substittuents in the 2-position and 6-position, their porduction, and their medicinal use

Info

Publication number
ZA813141B
ZA813141B ZA00813141A ZA813141A ZA813141B ZA 813141 B ZA813141 B ZA 813141B ZA 00813141 A ZA00813141 A ZA 00813141A ZA 813141 A ZA813141 A ZA 813141A ZA 813141 B ZA813141 B ZA 813141B
Authority
ZA
South Africa
Prior art keywords
different
substittuents
porduction
new
medicinal use
Prior art date
Application number
ZA00813141A
Inventor
E Wehinger
H Meyer
F Bossert
S Kazda
K Stoepel
R Towart
W Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA813141B publication Critical patent/ZA813141B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

1. Compound of the general formula I see diagramm : EP0039863,P18,F1 in which R represents a phenyl radical which optionally contains 1 or 2 identical or different substituents from the group comprising nitro, chlorine, cyano or trifluoromethyl, with the exception of a phenyl radical which is at the same time ortho- and metadichlorosubstituted, when R**2 denotes methyl and R**4 denotes alkyl with 2-3 carbon atoms, R**1 represents a saturated hydrocarbon radical with up to 6 carbon atons which is optionally interrupted by an oxygen atom, R**2 and R**4 are always different and each represents hydrogen, alkyl with 1 to 4 carbon atoms or cyclohexylmethyl, with the exception of the compound diethyl-2-methyl-6-propyl-4-(3-nitrophenyl)-1,4- dihydropyridine-3,5-carboxylate.
ZA00813141A 1980-05-13 1981-05-12 New 1,4-dihydropyridine compounds having different substittuents in the 2-position and 6-position, their porduction, and their medicinal use ZA813141B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803018259 DE3018259A1 (en) 1980-05-13 1980-05-13 1,4-DIHYDROPYRIDINE WITH DIFFERENT SUBSTITUENTS IN 2- AND 6-POSITIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS

Publications (1)

Publication Number Publication Date
ZA813141B true ZA813141B (en) 1982-04-28

Family

ID=6102290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00813141A ZA813141B (en) 1980-05-13 1981-05-12 New 1,4-dihydropyridine compounds having different substittuents in the 2-position and 6-position, their porduction, and their medicinal use

Country Status (17)

Country Link
EP (1) EP0039863B1 (en)
JP (1) JPS577468A (en)
AT (1) ATE5718T1 (en)
AU (1) AU541935B2 (en)
CA (2) CA1175438A (en)
DE (2) DE3018259A1 (en)
DK (1) DK210281A (en)
ES (2) ES502132A0 (en)
FI (1) FI811437L (en)
GR (1) GR74910B (en)
HU (1) HU184434B (en)
IE (1) IE51267B1 (en)
IL (1) IL62841A (en)
NO (1) NO811424L (en)
PH (1) PH18747A (en)
PT (1) PT72964B (en)
ZA (1) ZA813141B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3207982A1 (en) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICINAL PRODUCTS
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
JPS58208271A (en) * 1982-04-30 1983-12-03 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPS6094963A (en) * 1983-10-31 1985-05-28 Teijin Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative and production thereof
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3447169A1 (en) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen OPTICALLY ACTIVE NITRODIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
JPS625958A (en) * 1985-07-03 1987-01-12 Suntory Ltd 1,4-dihydropyridine derivative, production thereof and remedy for circulatory disease
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
JPH02501736A (en) * 1986-12-24 1990-06-14 ベリンガー　マンハイム　イタリア　エッセ　ピ　ア Novel aralkyl-1,4-dihydropyridine and method for producing the same, and pharmaceutical compositions containing the same
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
WO1991009847A1 (en) * 1989-12-29 1991-07-11 Kaken Pharmaceutical Co., Ltd. Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
ATE234286T1 (en) * 1993-12-10 2003-03-15 Bayer Ag PHENYL-SUBSTITUTED 1,4-DIHYDROPYRIDINES WITH CEREBRAL ACTIVITY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792764C3 (en) * 1967-03-20 1981-04-23 Bayer Ag, 5090 Leverkusen Coronary drugs
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE2508181A1 (en) * 1975-02-26 1976-09-09 Bayer Ag 1,4-DIHYDROPYRIDINCARBONIC ACID ARAL KYLESTER, METHOD FOR MANUFACTURING AND USING THEY AS A MEDICINAL PRODUCT
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE7910521L (en) * 1979-12-20 1981-06-21 Haessle Ab NEW 2-METHYL-6-SUBSTITUTED-4- (2,3-DISUBSTITUTED PHENYL) -1,4-DIHYDROPYRIDINE-3,5-DIESTERS WITH HYPOTHESIVE PROPERTIES, AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
CA1185182A (en) 1985-04-09
IL62841A (en) 1984-11-30
ATE5718T1 (en) 1984-01-15
HU184434B (en) 1984-08-28
IL62841A0 (en) 1981-07-31
GR74910B (en) 1984-07-12
AU541935B2 (en) 1985-01-31
PT72964B (en) 1982-06-25
ES8304082A1 (en) 1983-02-16
PT72964A (en) 1981-06-01
DK210281A (en) 1981-11-14
IE51267B1 (en) 1986-11-26
ES8300093A1 (en) 1982-10-01
DE3018259A1 (en) 1981-11-19
FI811437L (en) 1981-11-14
AU7047381A (en) 1981-11-19
CA1175438A (en) 1984-10-02
EP0039863A1 (en) 1981-11-18
DE3161760D1 (en) 1984-02-02
ES502132A0 (en) 1982-10-01
EP0039863B1 (en) 1983-12-28
ES512592A0 (en) 1983-02-16
JPS577468A (en) 1982-01-14
IE811061L (en) 1981-11-13
NO811424L (en) 1981-11-16
PH18747A (en) 1985-09-19

Similar Documents

Publication Publication Date Title
ZA813141B (en) New 1,4-dihydropyridine compounds having different substittuents in the 2-position and 6-position, their porduction, and their medicinal use
EP0151006A3 (en) Dihydropyridine compounds, their production, pharmaceutical compositions containing them, and methods of producing these compositions
GR3003776T3 (en)
HUT43787A (en) Process for production of medical compounds decreasing blood-pressure
GR75347B (en)
ATE1904T1 (en) 2-SULFONYL-QUINOXALINES, PROCESSES FOR THEIR PRODUCTION AND USE AS MICROBICIDES.
IT1215298B (en) 2- (ETEROALCHIL) -1,4-DIHYDROPYRIDINE AND A PROCESS FOR THEIR PRODUCTION.
ATE4951T1 (en) ISATOGEN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES.
ATE24892T1 (en) ALPHA,ALPHA-DIMETHYLPHENYLACETANILIDE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS INSECTICIDES.
DK362479A (en) PROCEDURE FOR MANUFACTURING THIOETHERS
TH2282EX (en) Phenylsulfonylguanidine with a new class of substitutes for the control of weeds and trail mixtures.
ATE50569T1 (en) ALPHA-ALLYLATED ARYLALKYLTRIAZOLES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES.
FR2525606B1 (en)
TH5961EX (en) Diphenyl ether type weed killer